Ignite Creation Date:
2024-05-05 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 9:55 AM
Study NCT ID:
NCT00760877
Status:
COMPLETED
Last Update Posted:
2016-11-08
First Post:
2008-09-25
Brief Title:
Nilotinib Versus Standard Imatinib 400600 mg Every Day QD Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase CML-CP Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction RQ-PCR
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis